SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.32+1.4%3:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (16792)4/14/2004 12:26:26 AM
From: Bluegreen  Read Replies (1) of 17367
 
Cacaito, I would still like to see a big flushing out of the Xoma stock price down to the 2 area. I feel most comfortable buying in that area. At the rate it is going down it MAY not be long. I am also hoping they can sign up around 10,000 patients for Raptiva by the end of the year just in the USA. As you know treating 10,000 patients a year is about 140 MILLION in revenue. Long term I am hoping that Raptiva can get JUST 20 percent of the 500,000 moderate to severe Psoriasis patients in JUST the USA. That would mean around 100,000 times around 13,000 to 14,000 which equals around 1.3 billion a year JUST in the USA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext